Gilead Sciences Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (460)

Latest Posts

About This Stock More About This Stock
Stocks Are Rising On The Appearance Of Massive Earnings “Beats”
Article By: Michael J. Kramer
Friday, July 31, 2020 9:15 AM EDT
Stocks are rising following the “strong” quarterly results last night.
In this article: TCEHY, AMZN, FB, QQQ, SPY, GILD
Read
Gilead Sciences Misses Q2 Earnings And Revenue Estimates
Article By: Zacks Investment Research
Thursday, July 30, 2020 6:21 PM EDT
Gilead Sciences came out with quarterly earnings of $1.11 per share.
In this article: GILD
Read
E Market Briefing For Monday, July 13
Article By: Gene Inger
Sunday, July 12, 2020 7:30 PM EDT
The world is piling into very expensive stocks; a shakeout looms out there, though probably not yet.
In this article: JPM, GILD Also: OIL
Read
E HIV Cure Challenger CytoDyn Takes On Gilead Sciences
Article By: Moon Kil Woong
Friday, July 3, 2020 11:10 AM EDT
CytoDyn believes they have a cure for HIV that will work on a subpopulation of patients with cancer.
In this article: CYDY, GILD Also: MRK
Read
Gilead Will Charge More Than $3,000 For A Course Of COVID-19 Drug Remdesivir
Article By: Tyler Durden
Monday, June 29, 2020 8:01 AM EDT
Gilead disclosed its pricing plan for Gilead as it prepares to begin charging for the drug at the beginning of next month (several international governments have already placed orders).
In this article: GILD
Read

PARTNER HEADLINES

Latest Tweets for $GILD

No tweets yet!

$GILD

Gilead Crohn's Treatment Is Not The Solution To GLD Revenue Issues
Kurt Benson 3/24/2017 10:12:59 PM

I have to agree with your assessment on $GILD. Do you know anything about $VBIO? I read a promising article here about their having a major breakthrough in #Crohn's research.

www.talkmarkets.com/.../interview-with-vitality-biopharma-inc

Not a lot of info on the company though.

Gilead Crohn's Treatment Is Not The Solution To GLD Revenue Issues
Kirk Sheffield 3/24/2017 10:11:55 PM

I think $GILD will rebound. This isn't the only product they have in their pipeline.

Gilead Crohn's Treatment Is Not The Solution To GLD Revenue Issues
Alpha Stockman 3/24/2017 10:07:45 PM

I've been rather disappointed with #Gilead myself. After reading your article, I'm planning to offload some $GILD.

Gilead Sciences Receives Canadian Approval For HIV Drug
David Reynolds 2/20/2017 10:04:11 PM

The opening up of this market for #GileadSciences should bode well for the stock $GILD.

Gilead Sciences: Cheap Growth Or Value Trap?
Karen Klein 9/13/2016 5:39:48 PM

Excellent analysis, you have effectively convinced me to change my position on #Gilead. $GILD

3 Cult Stocks To Avoid In 2015
Bruce Powers 1/26/2015 8:01:06 AM

Great article and glad to read the reasoning to consider $GILD as a safer investment short, mid and long term.

3 Cult Stocks To Avoid In 2015
BreakingBad News 1/25/2015 6:09:51 PM

Sorry all, thanks for the clarification. My bad! Now that I've read it through, it all makes total sense. $GILD, $BAC, $WFM, and $VA are my plays for 2015.

3 Cult Stocks To Avoid In 2015
BreakingBad News 1/25/2015 4:48:08 PM

I'd say this is a minority view, I've seen several others stating that $GILD was a stock to buy this year.

1 to 8 of 8 comments